Vanguard disaggregates holdings; reports 0% in ASP Isotopes (ASPI)
Rhea-AI Filing Summary
ASP Isotopes Inc: An amendment to a Schedule 13G/A states that The Vanguard Group reports 0% beneficial ownership of the issuer's common stock as of the amendment filing. The filing explains an internal realignment of Vanguard subsidiaries on January 12, 2026 that led to disaggregated reporting; Vanguard lists 0 shares and no voting or dispositive power.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial stake after internal realignment.
The amendment records 0 shares and 0% ownership, citing an internal reorganization on January 12, 2026 and separate reporting by certain subsidiaries in reliance on SEC Release No. 34-39538.
This filing is administrative: subsequent disclosures by Vanguard-affiliated entities could show holdings. Future filings by those entities would clarify any indirect positions.
The amendment documents compliance with SEC disaggregation guidance.
The text cites SEC Release No. 34-39538 as the basis for separate reporting by Vanguard subsidiaries and states that Vanguard "no longer has, or is deemed to have, beneficial ownership" of securities held by those units.
Watch for additional Schedule 13G/A or Form 13F entries from Vanguard subsidiaries for complete institutional ownership transparency.
FAQ
What does The Vanguard Group report for ASP Isotopes (ASPI)?
Why does Vanguard say it reports separately for some subsidiaries?
Does this amendment show any voting control by Vanguard over ASPI shares?
Who signed the Schedule 13G/A amendment for Vanguard?